Metastatic Colorectal Cancer Clinical Trials in Wuhan, Hubei
2 recruitingWuhan, Hubei, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Liu Huang42 enrolled1 locationNCT06980532
Recruiting
Not Applicable
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
Metastatic Colorectal Cancer
Liu Huang80 enrolled1 locationNCT06551207